Contents

Current Medicinal Chemistry, Volume 19 - Number 7

Editorial [ Hot Topic: Targeting Tumor Angiogenesis: An Update (Guest Editor: Girolamo Ranieri)]

, 19(7): 937

Girolamo Ranieri


DOI: 10.2174/092986712799320718




Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

, 19(7): 938 - 944

G. Ranieri, G. Gadaleta-Caldarola, V. Goffredo, R. Patruno, A. Mangia, A. Rizzo, R. L. Sciorsci and C. D. Gadaleta


DOI: 10.2174/092986712799320736




mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

, 19(7): 945 - 954

A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta and G. Ranieri


DOI: 10.2174/092986712799320727




Inflammation and Antiangiogenesis in Cancer

, 19(7): 955 - 960

D. Ribatti, E. Crivellato and A. Vacca


DOI: 10.2174/092986712799320655




Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues

, 19(7): 961 - 971

C. Sandomenico, R. Costanzo, G. Carillio, M. C. Piccirillo, A. Montanino, M. Di Maio, G. Rocco, N. Normanno, F. Perrone and A. Morabito


DOI: 10.2174/092986712799320673




Efficacy and Safety of Bevacizumab in Glioblastomas

, 19(7): 972 - 981

S. De Fazio, E. Russo, M. Ammendola, E. Donato Di Paola and G. De Sarro


DOI: 10.2174/092986712799320646




The Pharmacological Pathways of GnRH Mediating the Inhibition of Mammary Tumours: Implications in Humans and Domestic Animals

, 19(7): 982 - 991

A. Rizzo, M. Spedicato, M. Mutinati, G. Minoia, R. Patruno, G. Ranieri and R. L. Sciorsci


DOI: 10.2174/092986712799320745




DC-SIGN Antagonists, a Potential New Class of Anti-Infectives

, 19(7): 992 - 1007

M. Anderluh, G. Jug, U. Svajger and N. Obermajer


DOI: 10.2174/092986712799320664




Disease-Modifying Therapies in Frontotemporal Lobar Degeneration

, 19(7): 1008 - 1020

B. Bigni, E. Premi, A. Pilotto, A. Padovani and B. Borroni


DOI: 10.2174/092986712799320637




The Development of MetAP-2 Inhibitors in Cancer Treatment

, 19(7): 1021 - 1035

S.-Q. Yin, J.-J. Wang, C.-M. Zhang and Z.-P. Liu


DOI: 10.2174/092986712799320709




MMP-2 Selectivity in Hydroxamate-Type Inhibitors

, 19(7): 1036 - 1064

P. Serra, M. Bruczko, J. M. Zapico, A. Puckowska, M. A. Garcia, S. Martin-Santamaria, A. Ramos and B. de Pascual-Teresa


DOI: 10.2174/092986712799320628




Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance

, 19(7): 1065 - 1075

R. Nahta


DOI: 10.2174/092986712799320691




Gemcitabine: A Critical Nucleoside for Cancer Therapy

, 19(7): 1076 - 1087

D. S. Gesto, N. M.F.S.A. Cerqueira, P. A. Fernandes and M. J. Ramos


DOI: 10.2174/092986712799320682




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science